Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01011 NT PHARMA
RT Nominal unchange0.290 0.000 (0.000%)
Latest  |  Final  |  Interim
Non-current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others556-41.102%944495,717222,367419,830
Land & other Lease Assets0--0025,998117,998
Intangible Assets1981.538%195158,985160,835162,846
Interests in Asso. & JCEs320,8532.522%312,960277,013277,93616,899
Other Non-current Assets2,7530.255%2,746569521537

324,3602.372%316,845932,284687,657718,110
Current Assets
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Inventories0--010,31832,00527,287
Trade Receivables5,488-45.404%10,05233,66612,45225,964
Cash & Bank Balances5,791280.987%1,5205,9319,4437,694
Other Current Assets3,125343.262%70523,51933,803419,915
Assets Held for Sale0--00180,00096,099

14,40417.325%12,27773,434267,703576,959
Current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Trade Payables551-43.429%9748,47744,63046,697
S-T Debt & Leases353,0233.422%341,342825,991618,430799,404
Other Current Liabilities328,0411.633%322,771335,225232,913255,669
Liab asso w/ Assets Held for Sale0--00054,666

681,6152.485%665,0871,169,693895,9731,156,436
Net Current Assets(667,211)2.206%(652,810)(1,096,259)(628,270)(579,477)
Total Assets Less Current Liabilities(342,851)2.050%(335,965)(163,975)59,387138,633
Non-current Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
L-T Debt & Leases3,564-1.000%3,600463213,68052,051
Other Non-current Liabilities0--077,22057,08264,160

3,564-1.000%3,60077,683270,762116,211
Capital and Reserves
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
  Share Capital10.000%1111
  Reserves(346,416)2.017%(339,566)(241,659)(211,376)16,278
  Others0--0000
Shareholders' Funds(346,415)2.017%(339,565)(241,658)(211,375)16,279
Non-controlling Interests0--0006,143
Others0--0000

(346,415)2.017%(339,565)(241,658)(211,375)22,422
Commitments and Contingent Liabilities
2024/06 - Interim
RMB(K¥)
%Chg
(Compare to Final)
2023/12
RMB(K¥)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
Commitments----1,44020,00020,000380,510
Contingent Liabilities----0000
Remarks:  Real time quote last updated: 02/12/2024 09:22
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB 661,000
%Change--
EPS / (LPS)RMB 0.000
NBV Per Share (¥)RMB -0.131
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.